A novel hemostatic agent in endoscopic mucosal resection and endoscopic submucosal dissection

A novel hemostatic agent in endoscopic mucosal resection and endoscopic submucosal dissection - A novel hemostatic agent in EMR and ESD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011548

Enrollment

200

Registered

2013-08-21

Start date

2011-07-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early stage gastrointestinal cancer and adenoma

Interventions

hemostatic agents

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who undergo endoscopic resection for early esophageal, gastric and colorectal cancers or adenomas.

Exclusion criteria

Exclusion criteria: Difficult cases including hematologic disease for endoscopic resection.

Design outcomes

Primary

Measure	Time frame
Post-procedure bleeding	—

Secondary

Measure	Time frame
healing of defect after the procedure	—

Countries

Japan

Contacts

Public ContactToshio Uraoka

Keio University School of Medicine Division of Research and Development for Minimally Invasive Treatment, Cancer Center

turaoka@a3.keio.jp03-5363-3437

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026